Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Liver in F1-TKm30 mice: Control vs 4,4'-Methylenebis(2-chlorobenzenamine) treatment

ABSTRACT: Liver in F1-TKm30 mice: Control vs 4,4'-Methylenebis(2-chlorobenzenamine) treatment

PROVIDER: PRJNA1066358 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR27636922_1.fastq.gz	Fastqsanger.gz
	SRR27636922_2.fastq.gz	Fastqsanger.gz
	SRR27636923_1.fastq.gz	Fastqsanger.gz
	SRR27636923_2.fastq.gz	Fastqsanger.gz
	SRR27636924_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Liver in F1-TKm30 mice: Control vs 4,4'-Methylenebis(2-chlorobenzenamine) treatment

Project description:The gene expression profling between Control and 4,4'-Methylenebis(2-chlorobenzenamine) exposure for 4 weeks in liver of F1-TKm30 female mice.

2024-11-11 | GSE253615 | GEO

Liver in humanized-liver mice: Control vs 4,4'-Methylenebis(2-chlorobenzenamine) treatment

Project description:The gene expression profiling between Control and 4,4'-Methylenebis(2-chlorobenzenamine) exposure for 4 weeks in liver of F1-TKm30 female mice transplanted with commercially available human hepatocytes.

2024-11-11 | GSE253614 | GEO

Liver in humanized-liver mice: Control vs 4,4'-Methylenebis(2-chlorobenzenamine) treatment

Project description:Liver in humanized-liver mice: Control vs 4,4'-Methylenebis(2-chlorobenzenamine) treatment

| PRJNA1066354 | ENA

Liver in humanized-liver mice: Control vs ortho-toluidine treatment

Project description:Liver in humanized-liver mice: Control vs ortho-toluidine treatment

| PRJNA858765 | ENA

Human liver tissues: cancer vs. control

Project description:Human liver tissues: cancer vs. control

| PRJNA701644 | ENA

Liver in NOG-TKm30 mice: Control vs ortho-toluidine treatment

Project description:Liver in NOG-TKm30 mice: Control vs ortho-toluidine treatment

| PRJNA858761 | ENA

Paternal DCHP exposure on F1 male liver transcriptome

Project description:Purpose: To investigate the effects of DCHP expoure on F1 male hepatic metabolic disorders Methods: 8 week male WT mice were exposed to DCHP by oral gavage for 4 weeks, 3 week old F1 male mice were fed with HFD for 9 weeks, glucose and insulin tolerant tests were performed at 10-11 week old, liver RNA was isolated for further transcriptome analysis Results: Mice from DCHP exposure sires displayed glucose/insulin resistant phenotype, together with upregulation in inflammatoy related genes in the liver

2023-05-24 | GSE215806 | GEO

Mild vs advanced liver fibrosis

Project description:The aim of this study is to compare mild and advanced liver fibrosis gene expression profiling and to identify novel markers of fibrosis progression. By transcriptome analysis with a cDNA array virtually covering every transcript in liver, we compared transcript levels in mild (F1 Metavir score) and advanced (F4 Metavir score) fibrosis. A stringent selection identified a list of 16 transcripts which completely separated the 2 groups of patients (8 F1 and 8 F4). We report that dysregulations at the transcriptional level do exist between mild fibrosis (F1) and advanced fibrosis (F4). Keywords: fibrosis stage-dependent analysis

2008-05-24 | GSE11536 | GEO

Rat liver. Control vs. Chemical treated: time course

Project description:This SuperSeries is composed of the following subset Series: GSE16340: Rat liver. Control vs. Chemical treated, 3 days GSE16394: Rat liver. Control vs. Chemical treated, 28 days GSE16743: Rat liver: Control vs. Chemical treated, 14 days Refer to individual Series

2009-06-23 | E-GEOD-16752 | biostudies-arrayexpress

Mild vs advanced liver fibrosis

2008-05-24 | E-GEOD-11536 | biostudies-arrayexpress